Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.

Sofia Axia KarlssonChristel HeroAnn-Marie SvenssonStefan FranzénMervete MiftarajSoffia GudbjörnsdottirKatarina Eeg-OlofssonBjörn EliassonKarolina Andersson Sundell

Published in: BMJ open (2018)

Higher refill adherence to lipid-lowering medications was associated with lower risk of CVD in primary and secondary prevention patients with type 2 diabetes mellitus.

Keyphrases

end stage renal disease
cardiovascular disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
type diabetes
metabolic syndrome
patient reported outcomes
patient reported